Ikena Oncology, Inc. (IKNA) Tops Q2 EPS by 8c

Ikena Oncology, Inc. (NASDAQ: IKNA) reported Q2 EPS of ($0.28), $0.08 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Ikena Oncology, Inc. (IKNA) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Sigma Lithium resumes full operations after signing TAC agreement
• Is the global equity rally broadening? UBS weighs in